Crossmark

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy

Crossref DOI link: https://doi.org/10.1186/s12885-020-07351-w

Published Online: 2020-09-03

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Zhao

Wu, Hongliang

Yang, Tong

Wu, Yaohai

Yu, Nengwang https://orcid.org/0000-0002-9131-8166
Xu, Zhonghua
Funding

Funding for this research was provided by:

the Focused Research and Development Program of Shandong Province (2017GSF18162)

the Focused Research and Development Program of Shandong Province (2017GSF18130)

the Natural Science Foundation of Shandong Province (ZR2018MH024)
License Information

Text and Data Mining valid from 2020-09-03

Version of Record valid from 2020-09-03
More Information

Article History

Received: 15 March 2020

Accepted: 26 August 2020

First Online: 3 September 2020

Ethics approval and consent to participate

: We obtained the permission to access the SEER database with the ID number 10616-Nov2018 via Internet access method. Ethical approval was waived by the local ethics committee, as SEER data is publicly available, de-identified.

: Not applicable.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below